Streetbeat News

Stock Prices

KZIA

Kazia Therapeutics' stock price increased following the announcement of the early conclusion of its Phase 1 Paxalisib trial in solid tumors, having reached its primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 12:42 pm

KHC

Kraft Heinz reiterates its 2024 financial outlook, expecting organic net sales growth of 0%-2%, adjusted operating income growth of 2%-4%, and adjusted EPS of $3.01-$3.07, aligning with a $3.03 estimate. The company anticipates positive price contributions and volume increases in the second half, with a modest expansion in adjusted gross profit margin. Challenges include a potential $45 million impact from foreign currency and debt refinancing.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 12:41 pm

PHIN

Phinia reported a significant decrease in its Q4 adjusted EPS to $0.71 from $1.75 YoY, despite a slight increase in sales to $882.00M from $851.00M YoY.

Portfolio Pulse from mahesh@benzinga.com

February 21, 2024 | 12:37 pm

BFH

Bread Financial has announced the approval of a new $30 million share repurchase program, signaling confidence in the company's financial health and future prospects.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 12:36 pm

KEYS

Keysight Technologies Inc. (NYSE:KEYS) shares fell in premarket trading on Wednesday despite reporting Q1 2024 earnings and revenues that beat analyst expectations. The decline is attributed to year-over-year revenue drops in its Communications Solutions Group and Electronic Industrial Solutions Group, along with decreased cash flow from operations and free cash flow. The company's Q2 revenue and non-GAAP EPS forecasts also fell short of estimates.

Portfolio Pulse from Nabaparna Bhattacharya

February 21, 2024 | 12:34 pm

THTX

Theratechnologies (NASDAQ:THTX) reported Q4 earnings with losses of $(0.08) per share, surpassing the $(0.24) estimate, and sales of $23.45M, slightly above the $23.36M estimate. This represents an improvement over the previous year's performance.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 12:33 pm

ROCK

Gibraltar Industries (NASDAQ:ROCK) reported Q4 adjusted EPS of $0.85, meeting analyst estimates, with an 18.06% increase over last year. However, sales of $328.80M missed estimates by 0.76%, though they were up 4.76% from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 12:32 pm

RGEN

Repligen (NASDAQ:RGEN) reported Q4 earnings of $0.33 per share, meeting analyst estimates, and sales of $155.74M, slightly beating the $155.39M estimate. This represents a 51.47% decrease in earnings and a 16.61% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 12:32 pm

GRMN

Garmin's shares surged following the announcement of its Q4 financial results, with FY24 revenue guidance surpassing expectations. The company also plans to increase its annual dividend and has authorized a share buyback program.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 12:30 pm

HSBC

HSBC Holdings PLC (NYSE:HSBC) shares dropped in premarket trading after reporting a decline in fourth-quarter revenue by 11% year-over-year to $13.021 billion, with net interest income (NII) falling 7% to $8.28 billion. The decline was attributed to notable items totaling $(2.7) billion. Despite the quarterly decline, FY23 saw a revenue increase of over 30% to $66.1 billion, with a significant rise in profit before tax to $30.3 billion, although below analysts' expectations. The bank also announced a new share buyback of up to $2.0 billion and a fourth interim dividend of $0.31 per share, with a total 2023 dividend of $0.61 per share. HSBC expects NII of at least $41 billion and a return on tangible equity in the mid-teens for 2024.

Portfolio Pulse from Lekha Gupta

February 21, 2024 | 12:26 pm